Welcome to our dedicated page for Enact Holdings SEC filings (Ticker: ACT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Enact Holdings, Inc. filings document the formal disclosures of a U.S. private mortgage insurance company. Form 8-K reports furnish quarterly and annual operating results, press releases, and financial supplements covering mortgage insurance performance, capital sufficiency, insurance in force, book value, and related financial measures.
The company's regulatory filings also cover proxy governance, board and stockholder voting matters, executive compensation, capital-return actions, stock repurchase arrangements involving Genworth Financial, and financing agreements such as its revolving credit facility. These records describe Enact's public-company governance, capital structure, liquidity arrangements, and material events tied to its mortgage insurance operations.
Enact Holdings, Inc. director Michael A. Bless received a grant of 3,939.791 Deferred Stock Units on May 13, 2026 as part of his annual retainer fee. These units are a form of stock-based compensation tied to the company’s common stock.
The grant was recorded at a price of $43.149 per share of common stock for fee-conversion purposes, though the units themselves have a stated transaction price of $0.00 because this is a compensation award, not a market purchase. Following the grant, Bless holds a total of 30,571.329 Deferred Stock Units.
Under the plan terms, these Deferred Stock Units become payable in shares of common stock one year after he terminates service as a director, so they function as long-term, non-cash compensation that aligns his interests with other shareholders over time.
RESTREPO ROBERT P JR reported acquisition or exercise transactions in this Form 4 filing.
Enact Holdings, Inc. director Robert P. Restrepo Jr. received a grant of 3,939.791 Deferred Stock Units as part of his annual retainer fee. These units will be paid out in shares of Common Stock one year after he ceases serving as a director, bringing his total Deferred Stock Units to 34,645.248.
Enact Holdings, Inc. reported the results of its Annual Meeting of Stockholders held on May 13, 2026. Shareholders elected eleven directors to serve until the 2027 annual meeting, with each nominee receiving more than 127.9 million votes "For."
Stockholders also approved, on an advisory basis, the compensation of the company’s named executive officers, with 137,729,223 votes "For" and 538,585 "Against." In addition, they ratified the appointment of KPMG LLP as independent registered public accounting firm for the 2026 fiscal year, with 138,540,938 votes "For" and 765,884 "Against."
Enact Holdings, Inc. generated solid Q1 2026 results with net income of $167.8M, up slightly from $165.8M a year earlier. Total revenue was $312.1M, supported by higher net investment income of $70.9M.
New insurance written reached $12.8B, about 30% above Q1 2025, driven by increased refinance activity, while the loss ratio rose to 15% from 12% as new delinquencies increased but still benefited from $39M of favorable reserve development.
Capital strength remained high: under PMIERs, available assets of $5,016M exceeded required assets of $3,097M by $1,919M (sufficiency ratio 162%). The company continued sizable shareholder returns, repurchasing 2.29 million shares for $93.2M and paying a $0.21 per-share dividend, with a new $500M repurchase authorization and a planned dividend increase to $0.24.
Enact Holdings, Inc. reported solid first quarter 2026 results, generating GAAP net income of $168 million, or $1.18 per diluted share, and adjusted operating income of $172 million, or $1.21 per diluted share. Primary insurance in-force was $272 billion, up about 2% year over year, while new insurance written was $13 billion, 30% higher than the prior-year quarter despite being down sequentially.
The loss ratio rose to 15% from 7% in the prior quarter as losses incurred increased to $37 million, though operating expenses fell to $49 million, improving the expense ratio to 20%. Book value per share reached $38.09, and adjusted operating return on equity was 12.9%.
Capital strength remained notable, with PMIERs sufficiency at 162% and about $1.9 billion above required assets. The company returned capital through roughly $30 million in common dividends and about $93 million of share repurchases in the quarter, and the board approved a 14% increase in the quarterly dividend to $0.24 per share.
Enact Holdings, Inc. reported solid first quarter 2026 results, generating GAAP net income of $168 million, or $1.18 per diluted share, and adjusted operating income of $172 million, or $1.21 per diluted share. Primary insurance in-force was $272 billion, up about 2% year over year, while new insurance written was $13 billion, 30% higher than the prior-year quarter despite being down sequentially.
The loss ratio rose to 15% from 7% in the prior quarter as losses incurred increased to $37 million, though operating expenses fell to $49 million, improving the expense ratio to 20%. Book value per share reached $38.09, and adjusted operating return on equity was 12.9%.
Capital strength remained notable, with PMIERs sufficiency at 162% and about $1.9 billion above required assets. The company returned capital through roughly $30 million in common dividends and about $93 million of share repurchases in the quarter, and the board approved a 14% increase in the quarterly dividend to $0.24 per share.
Genworth Holdings, Inc., a major shareholder of Enact Holdings, Inc., reported an open-market sale of 560,453 shares of Enact common stock. The shares were sold at $42.5521 per share under a Share Repurchase Agreement between Enact and Genworth dated February 2, 2026.
Following this transaction, Genworth Holdings directly owns 112,809,079 Enact shares and, according to the filing, holds approximately 81% of Enact’s outstanding common stock. The sale price was determined pursuant to the Agreement based on a weighted average price paid by Enact for purchases from third parties.
Enact Holdings, Inc. Controller James McMullen exercised restricted stock units that converted into 594 shares of common stock on a one-for-one basis. To cover taxes on the vesting that occurred on April 1, 2026, 169 of these shares were withheld by the company. After these transactions, McMullen directly held 1,697 shares of Enact common stock. The restricted stock units vest in three equal annual installments beginning on April 1, 2025.
Genworth Holdings, Inc., the controlling stockholder of Enact Holdings, Inc., reported an open-market style sale of 820,567 shares of Enact common stock on March 31, 2026 at an average price of $40.9224 per share.
The transaction was effected under a Share Repurchase Agreement between Enact and Genworth dated February 2, 2026. After this sale, Genworth directly holds 113,369,532 Enact shares and owns approximately 81% of Enact’s outstanding common stock, so the sale represents a small portion of its overall stake.
Enact Holdings, Inc. has called its 2026 virtual annual meeting for May 13, 2026 at 11:00 a.m. ET, asking stockholders to elect eleven directors, approve an advisory vote on executive pay, and ratify the 2026 independent auditor.
The proxy highlights a strong 2025, with net income of $674 million, $52 billion of new insurance written, and a record $273 billion of insurance in-force. Capital remained robust, including $1.9 billion of PMIERs sufficiency, or 162% of requirements, and over $500 million returned to shareholders through dividends and buybacks, contributing to an approximate 25% total shareholder return.
Enact emphasizes disciplined execution of its strategy, including deployment of its Rate360 pricing engine, expansion of Enact Re, operating expenses of $218 million (down 2% from 2024), and a new $435 million revolving credit facility. Since its IPO, the company has returned over $1.6 billion to shareholders and reports that 2023 performance stock units vested at 200% of target based on maximum book value per share growth.